Head-to-head
Hims & Hers vs Amble Health
Compared on tirzepatide across the eight dimensions this database records. They differ on 8 of those eight. Amble Health is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Hims & Hers is $697 a month all-in for tirzepatide; Amble Health is $300. Over twelve months that is $8,364 against $3,600. Value Scores are 27.5 and 67.2 out of 100.
Tirzepatide
Plan pages: Hims & Hers plans · Amble Health plans
At 10 mg/week, Hims & Hers is $697 a month all-in and Amble Health is $300 — $397 apart, or $4,764 across a year. Over twelve months the totals are $8,364 (billed monthly) and $3,600 (billed monthly).
Hims & Hers charges a flat $548 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
Amble Health charges a flat $300 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | Hims & Hers | Rank | Amble Health | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $548 | 30/31 | $300 | 21/31 | Amble Health by $248 |
| 5 mg | — | — | $300 | 11/17 | only Amble Health publishes |
| 7.5 mg | — | — | $300 | 11/17 | only Amble Health publishes |
| 10 mg | $548 | 25/27 | $300 | 15/27 | Amble Health by $248 |
| 12.5 mg | — | — | $300 | 11/17 | only Amble Health publishes |
| 15 mg | — | — | $300 | 11/17 | only Amble Health publishes |
Amble Health is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, Hims & Hers sits 25 of 27 on all-in monthly cost and Amble Health sits 13. There are 11 other programs priced between them. The field median is $339 and the floor is $169, so Amble Health is below the median and the other is above it. Hims & Hers is $528 above the cheapest tirzepatide program on record. Amble Health is $131 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Hims & Hers undercuts it by $-248, Amble Health by $149. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Hims & Hers | Amble Health | Cheaper |
|---|---|---|---|
| Month to month | $548 | $300 | Amble Health by $248 |
| Settled dose | Hims & Hers | Amble Health | Difference |
|---|---|---|---|
| 2.5 mg | $8,364 | $3,600 | $4,764 apart |
| 5 mg | — | $3,600 | one side unpriced |
| 7.5 mg | — | $3,600 | one side unpriced |
| 10 mg | $8,364 | $3,600 | $4,764 apart |
| 12.5 mg | — | $3,600 | one side unpriced |
| 15 mg | — | $3,600 | one side unpriced |
Hims & Hers publishes no rate for 3-month term, 6-month term, 12-month term; Amble Health publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $8,364 on Hims & Hers and $3,600 on Amble Health. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Hims & Hers publishes no price at 2 of the 6 doses, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 27.5 for Hims & Hers and 67.2 for Amble Health, against a tirzepatide category floor of $169. Amble Health leads by 39.7 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Hims & Hers | 17.0 | 10.5 | 0 | 0 | 27.5 |
| Amble Health | 39.4 | 12.8 | 10 | 5 | 67.2 |
Where the two programs differ
All-in monthly
Amble Health is cheaper month to month — $300 against $697, a gap of $397 every month, or $4,764 across a year if both rates hold.
Cancellation terms
Cancellation differs: Hims & Hers states Cancel anytime, while Amble Health states Cancel before renewal. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Hims & Hers asks for Membership month-to-month ($39 first month); Amble Health asks for Month-to-month. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Amble Health charges one price at every dose; Hims & Hers prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. Hims & Hers's figure is reported and Amble Health's is provider-stated. Amble Health rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Membership fee
Hims & Hers charges a membership of $149 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Shipping
Hims & Hers bills shipping separately at $5; the other includes it.
Twelve-month cost
Over twelve months the totals are $8,364 for Hims & Hers and $3,600 for Amble Health. Amble Health is lower by $4,764 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
What each record says
Hims & Hers Official site
After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping.
It names its compounding pharmacy — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy, recorded as Brand channel — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Membership month-to-month ($39 first month); cancellation is Cancel anytime; availability is stated as 50 states.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — Post-settlement pricing reported May–Jun 2026 (Wegovy $299 / oral $249 / Zepbound $399 + $149 membership + $5 shipping); first-party checkout capture pending
Watch: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Amble Health Official site
A no-membership program with $300/month flat tirzepatide.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Availability at intake.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — amblehealth.com pricing capture 2026-08-05
Watch: Provider-stated; checkout capture pending.
Which molecules each one carries
Hims & Hers carries tirzepatide at $697 a month and semaglutide at $602 a month.
Amble Health carries tirzepatide at $300 a month; does not offer semaglutide.
Comparable only on tirzepatide: they do not both publish a rankable semaglutide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Hims & Hers does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
Amble Health does not publish
- no published twelve-month tirzepatide rate
- no named compounding pharmacy
Ask Hims & Hers and Amble Health for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Hims & Hers carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Amble Health Official site wins this matchup. If you expect to titrate to the top of the ladder, amble health's flat pricing is worth more than the headline gap suggests; if you want to be able to pause without still paying, amble health carries no membership; and if you would rather trust a better-evidenced number, amble health's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Hims & Hers's tirzepatide price is reported as of 2026-08-11; Amble Health's is provider-stated as of 2026-08-05.
Questions
Is Hims & Hers or Amble Health cheaper for tirzepatide?
Amble Health is cheaper on all-in monthly cost at 10 mg/week: $300 against $697, a difference of $397 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Hims & Hers versus Amble Health?
Hims & Hers works out to $8,364 across twelve months and Amble Health to $3,600, on the plan terms each publishes.
Does Hims & Hers or Amble Health raise the price as the dose goes up?
Hims & Hers: yes, it prices by dose. Amble Health: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Hims & Hers and Amble Health differ?
8 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Hims & Hers and Amble Health names its pharmacy?
Hims & Hers does — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy. Amble Health does not, recording only Partner pharmacies, so who makes its medication cannot be independently verified.
How well evidenced are the Hims & Hers and Amble Health prices?
Hims & Hers's tirzepatide figure is reported — sourced from dated third-party reporting; first-party capture pending — captured 2026-08-11. Amble Health's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Hims & Hers official site · Amble Health official site. Compounded tirzepatide and semaglutide are not FDA-approved products.